Pathogen inactivation of cellular blood products -: Still plenty of reason to be careful

被引：4
|
作者：
Caspari, G
Gerlich, WH
Kiefel, V
Gürtler, L
机构：
[1] Univ Giessen, Inst Med Virol, Giessen, Germany
[2] Univ Greifswald, Friedrich Loffler Inst Med Mikrobiol, Greifswald, Germany
来源：
TRANSFUSION MEDICINE AND HEMOTHERAPY | 2005年 / 32卷 / 05期
关键词：
D O I：
10.1159/000085684
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 260
页数：3
相关论文
共 50 条
  • [1] Pathogen inactivation in blood products
    Wainwright, M
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (01) : 127 - 143
  • [2] Pathogen inactivation of cellular blood products -: More security for the patient or less?
    Caspari, G
    Gerlich, WH
    Gürtler, L
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2003, 30 (06) : 261 - 263
  • [3] Pathogen inactivation in labile blood products
    Naegelen, C.
    Isola, H.
    Dernis, D.
    Maurel, J. -P.
    Tardivel, R.
    Bois, S.
    Vignoli, C.
    Cazenave, J. -P.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2009, 16 (02) : 179 - 189
  • [4] Pathogen inactivation of labile blood products
    Bopp, MKF
    Morell, A
    Indrak, K
    Parkkinen, J
    Mertens, H
    Mohr, H
    Colamartino, P
    Stanescu, I
    Oyonarte, S
    Delaney, FM
    Padilla, A
    TRANSFUSION MEDICINE, 2001, 11 (03) : 149 - 175
  • [5] Pathogen Inactivation of Cellular Blood Products-An Additional Safety Layer in Transfusion Medicine
    Seltsam, Axel
    FRONTIERS IN MEDICINE, 2017, 4
  • [6] Phenothiazinium derivatives for pathogen inactivation in blood products
    Wainwright, Mark
    Mohr, Harald
    Walker, Wolfram H.
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2007, 86 (01) : 45 - 58
  • [7] NAT SCREENING AND PATHOGEN INACTIVATION FOR BLOOD PRODUCTS
    Seifried, E.
    Schmidt, M.
    Mueller, M.
    VOX SANGUINIS, 2009, 97 : 22 - 22
  • [8] Pathogen Inactivation Technologies for Cellular Blood Components: an Update
    Schlenke, Peter
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (04) : 309 - 325
  • [9] Pathogen inactivation processes applicable to cellular products: The Canadian perspective
    Delage, G.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2011, 18 (04) : 485 - 487
  • [10] VIRAL INACTIVATION AND REDUCTION IN CELLULAR BLOOD PRODUCTS
    FRIEDMAN, LI
    STROMBERG, RR
    REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1993, 36 (01): : 83 - 91
12345